Primo Brands $1.5 billion debut secondary offering
The shares are listed on the New York Stock Exchange
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
Beam Therapeutics $500 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
Axon Enterprise $1.75 billion senior notes offering
The high-yield notes are due 2030 and 2033
Verisk $700 million senior notes offering
We advised Verisk on the SEC-registered notes
Trial victory against LG Electronics affirmed
The Delaware Supreme Court affirmed a ruling that LG invalidly removed our clients from the board of directors of Alphonso
Endo divestiture of International Pharmaceuticals business
We are advising Endo on the transaction
Accuride confirms and consummates chapter 11 plan
We advised the ABL agent in connection with the chapter 11 bankruptcy case
Strategy $21 billion perpetual strike preferred stock at-the-market offering
The perpetual strike preferred stock is listed on the Nasdaq Global Select Market
Victory in Tuya securities litigation
We secured dismissal of a putative securities class action filed in the Southern District of New York